(irinotecan HCl)

Prescribing Information
Download Prescribing Information

16 HOW SUPPLIED/STORAGE AND HANDLING

16 HOW SUPPLIED/STORAGE AND HANDLING

CAMPTOSAR (irinotecan hydrochloride) Injection is available as a sterile, pale yellow, clear, aqueous solution in an amber colored polypropylene CYTOSAFE® vial packaged as follows:

Unit of Sale

Total Strength/Total Volume

(Concentration)

NDC 0009-7529-04

Carton of 1 single-dose vial

40 mg/2 mL

(20 mg/mL)

NDC 0009-7529-03

Carton of 1 single-dose vial

100 mg/5 mL

(20 mg/mL)

NDC 0009-7529-05

Carton of 1 single-dose vial

300 mg/15 mL

(20 mg/mL)

CAMPTOSAR (irinotecan hydrochloride) Injection is available as an amber colored ONCO‑TAIN® glass vial packaged as follows:

Unit of SaleTotal Strength/Total Volume
(Concentration)

NDC 0009-7529-10

Carton of 1 single-dose vial

40 mg/2 mL

(20 mg/mL)

NDC 0009-0112-05

Carton of 1 single-dose vial

100 mg/5 mL

(20 mg/mL)

NDC 0009-0082-02

Carton of 1 single-dose vial

300 mg/15 mL

(20 mg/mL)

ONCO-TAIN® is the vial external protection system.

Store at controlled room temperature 15°C to 30°C (59° to 86°F). Protect from freezing. Protect from light. Keep the vial in the carton until the time of use.

Inspect the vial for damage and visible signs of leaks before removing from the carton. If damaged, incinerate the unopened package.

CAMPTOSAR is a hazardous drug. Follow special handling and disposal procedures.1

Additional Resources

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.

Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.

Available 9AM-5PM ET Monday to Friday; excluding holidays.

 

Submit a medical question for a Pfizer medicine or a vaccine. 

The submission will be reviewed during our standard business hours.

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information: 
Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.